You are here
The Fundamental Review of the National Efficient Price (NEP) was commissioned by IHPA to review the methodology underpinning the National Pricing Model. IHPA engaged Ernst & Young (EY), KPMG and PricewaterhouseCoopers (PwC) to independently perform the review in close consultation with IHPA’s advisory committees.
This report was prepared in accordance with the requirements of the National Health Reform Act 2011 and section 46 of the Public Governance, Performance and Accountability Act 2013. The report includes IHPA's audited Financial Statements, as required by section 42 of the Public Governance, Performance and Accountability Act.
IHPA requires accurate activity, cost and expenditure data from jurisdictions on a timely basis in order to perform its core determinative functions. This data plan sets out IHPA's seventh rolling Three Year Data Plan, covering the period 2019-20 to 2021-22. The Three Year Data Plan specifies the data requirements and timelines that IHPA will use to collect data over the next three years.
The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of Section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price (NEP) Determination 2019-20 (Determination):